Equities researchers at StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD – Get Free Report) in a research note issued on Thursday. The brokerage set a “sell” rating on the medical equipment provider’s stock.
Aethlon Medical Stock Performance
Shares of Aethlon Medical stock opened at $0.40 on Thursday. The stock has a 50 day moving average of $0.41 and a 200 day moving average of $0.57. The firm has a market capitalization of $5.56 million, a price-to-earnings ratio of -0.08 and a beta of 1.74. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $2.35.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.10. During the same period in the previous year, the firm earned ($1.30) EPS. Analysts forecast that Aethlon Medical will post -1.1 EPS for the current year.
About Aethlon Medical
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Featured Stories
- Five stocks we like better than Aethlon Medical
- What Are Dividend Contenders? Investing in Dividend Contenders
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- How to Calculate Stock Profit
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- What are earnings reports?
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
